48 news items
Page 2 of 3
o0ucdumlknk0zv0102uy070gl9igk uz99y7g
BMY
23 May 24
and overall response rate data from the Phase 3 KRYSTAL-12 study evaluating
nrkmq4n5tknkw11f5vn4hpz bf
BMY
SNY
22 May 24
.
In response to the ruling, Reuters noted that Bristol Myers and Sanofi released a joint statement expressing their disagreement
hasrc2tp0oxyc6s68x728h flo3w5ngduw4
BMY
16 May 24
Following four years of continuous Sotyktu treatment, clinical response was maintained in more
j0a 7gas3hc
BMY
16 May 24
four years of continuous Sotyktu treatment, clinical response was maintained in more than seven out of 10
w9o9r6hlrky3ze0 g13wezp5rkv560n
BMY
15 May 24
with median duration of response not reached and the majority (77.1%) of responders in ongoing response at 18 months
fuk8f3o18qa 9t
BMY
10 May 24
overall survival (OS) across the study arms, PFS by RECIST 1.1 per BICR across the study arms, as well as objective response rate (ORR), time
zfi8dlw92x8mbgoyhtvqcl6rq2ntpvzt1i
BMY
29 Apr 24
, it will deploy DECODE to monitor immune responses to the tolerizing vaccines in patients during clinical development to provide key insights
1sbmron
BMY
26 Apr 24
', or 'Lower' their stance, it signifies their response to recent developments related to Bristol-Myers Squibb. This offers insight into analysts' perspectives
78grn shgc
BMY
26 Apr 24
of care for decades but the durability of response to chemotherapy alone is poor and once a patient progresses, treatment options become increasingly
x21ry9l
BMY
25 Apr 24
response
tmb al6fe7ndvii
AGEN
BMY
12 Apr 24
response rate (ORR) was observed after a median follow up of 13.6 months at the data cutoff of March 1, 2024.
The median duration
ncu 5n9t0lm250l2pejann
BMY
JNJ
MRK
10 Apr 24
continues to build its heart business.
Johnson & Johnson is focusing on enhancing its cardiovascular health business in response to its
eh3vuy8hg3k4je3eopmvhbxyw3cyxfu5ub7genn070t6r8
BMY
8 Apr 24
.
With a median follow-up of 11.9 months in 94 patients, Krazati plus cetuximab demonstrated an objective response rate, the primary endpoint, of 34%, median